There are two newly-approved treatments to treat Alzheimer’s Disease, but getting them covered by medicare is a battle.
Alzheimer’s impacts nearly 6 million Americans over the age of 65, and that number is expected to triple by 2060. It is the sixth leading cause of death in the U.S., according to the CDC.
“It is always fatal. There is no cure. That's why we need to get more therapies. We, until recently, had not had a therapy approved by the FDA in over 20 years,” Dwyer said.“We started to notice there were a few details in Jenny’s memory that were falling through the cracks,” Joe Knap said. “Jenny was at very high risk for developing dementia and Alzheimer’s.”
But they weren’t going to hide from the diagnosis. Jenny Knap went to Cleveland Clinic and was eligible to be a part of a clinical trial for a new treatment. In a press release, CMS said there is not yet evidence meeting the criteria for reconsideration and CMS is required to examine whether a medication is reasonable and necessary. It said it will review any new evidence that becomes available that could lead to a reconsideration.“Medicare is taking a position with this whole class of drugs for the first time in history and said if the FDA approves it, it's not good enough for us. We're going to put up more barriers.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
New Surprising Benefits of Coffee: Reducing Non-Alcoholic Fatty Liver Disease Severity for Type 2 DiabeticsAccording to a recent study published in the journal Nutrients by the University of Coimbra, caffeine, polyphenols, and other natural compounds in coffee could play a role in decreasing the severity of non-alcoholic fatty liver disease (NAFLD) in overweight individuals with type 2 diabetes (T2D).
続きを読む »
New FDA-approved drug can slow vision loss for those with age-related eye diseaseSyfovre will be available as an injection in early March.
続きを読む »
Houston facility to pay $21M in alleged Medicare scheme in which unlicensed medical students performed proceduresA Houston medical center agreed last week to pay over $21 million to the federal government to settle alleged false Medicare claims submitted after procedures weren't covered or that were performed so poorly the procedures were deemed 'worthless.'
続きを読む »
Supreme Court Takes Up Case Brought by Payday Lenders to Destroy Consumer Protection AgencyThe Supreme Court has agreed to take up a case brought against a consumer protection agency that could unleash a deluge of abusive financial practices onto the public, and threaten to end entire welfare programs like Social Security and Medicare.
続きを読む »
Amyloid Gains Converts in Debate Over Alzheimer’s TreatmentsThe drug’s success has helped quell a dispute over a theory of what causes the disease and how to treat it. However, critics say scientists still aren’t sure how amyloid removal slows down Alzheimer’s.
続きを読む »